This paper considers physician agency in choosing drugs to treat metastatic breast cancer, a clinical setting in which patients have few protections from physicians’ rent seeking. Physicians have explicit financial incentives attached to each potential drug treatment, with profit margins...

The cost of early retirement associated with patients with PD was substantial. Given that the proportion of Americans participating in the labour force in older age groups is expected to increase, PD-related early retirement costs will likely rise. </AbstractSection> Copyright Adis Data Information BV 2011

<Emphasis Type="Bold">Objective: To determine and compare the cost utilities of the tumour necrosis factor (TNF) antagonists adalimumab and infliximab as maintenance therapies for patients in the US with moderately to severely active Crohn’s disease. <Emphasis Type="Bold">Methods: Maintenance regimens of adalimumab (40 mg every other...</emphasis></emphasis>

Direct costs for newly diagnosed PD patients exceeded costs for controls without PD, and increased with PD progression. Direct costs were approximately 6–7 times higher in patients with advanced PD than in matched controls. Indirect costs represented 45 % of total excess costs for newly...

Background:Background: The indirect costs of Parkinson's disease (PD) may be larger than direct healthcare costs, and the largest component of indirect costs is income loss related to early retirement. No recent retrospective analysis details PD-related early retirement and income loss in the...

Individuals with finite private information independently choose acts and messages. Their utilities may depend on all acts and information, including the center's. Incentive payments are separable and fully transferable. Implementable incentives making specified behavior a Bayesian equilibrium...

Objective: To determine and compare the cost utilities of the tumour necrosis factor (TNF) antagonists adalimumab and infliximab as maintenance therapies for patients in the US with moderately to severely active Crohn's disease. Methods: Maintenance regimens of adalimumab (40 mg every other...